Clovis Oncology
CLVS
#10292
Rank
NZ$20.42 M
Marketcap
NZ$0.14
Share price
0.00%
Change (1 day)
-95.20%
Change (1 year)

Market capitalization of Clovis Oncology (CLVS)

Last known market cap: NZ$20.42 Million

On February 22, 2023 Clovis Oncology had a market cap of NZ$20.42 Million. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Clovis Oncology from 2011 to 2023

End of year Market Cap

Year Marketcap Change
2023NZ$18.61 M0.4%
2022NZ$18.53 M-96.38%
2021NZ$0.51 B-25.75%
2020NZ$0.68 B-18.91%
2019NZ$0.85 B-39.82%
2018NZ$1.41 B-70.68%
2017NZ$4.82 B94.84%
2016NZ$2.47 B26.14%
2015NZ$1.96 B-19.22%
2014NZ$2.42 B-2.32%
2013NZ$2.48 B387.74%
2012NZ$0.50 B30.33%
2011NZ$0.39 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
NZ$20.38 B 99,708.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$491.46 B 2,406,522.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$248.49 B 1,216,711.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$862.65 B 4,224,127.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$695.52 B 3,405,731.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.666 T 8,160,233.88%๐Ÿ‡บ๐Ÿ‡ธ USA